Saturday, October 31, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Data updated Oct 31, 2026·New filings added every weekday·Weekly prices as of Oct 2·What changed·
Insider tradingForm 4

PharmaCyte Biotech, Inc. (PMCB) Insider Trading

6 open-market trades reported since Jan 7, 2026: 6 purchases worth $129K and 0 sales worth $0.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Joshua SilvermanCEO3$80K0$0Jan 7, 2026
Jonathan SchechterDirector3$48K0$0Jan 7, 2026

All trades

PMCB insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueScoreHolding3 mo. afterFiling
Jan 7Jan 7Joshua SilvermanCEOCEO▲ BUY40,0000.8329$33K50+11%Form 4 ↗
Jan 7Jan 6Joshua SilvermanCEOCEO▲ BUY30,0000.7889$24K43+8.7%Form 4 ↗
Jan 7Jan 5Joshua SilvermanCEOCEO▲ BUY30,0000.7831$23K43+9.5%Form 4 ↗
Jan 7Jan 7Jonathan SchechterDirectorDirector▲ BUY20,0000.8436$17K39+12%Form 4 ↗
Jan 7Jan 6Jonathan SchechterDirectorDirector▲ BUY20,0000.7904$16K39+13%Form 4 ↗
Jan 7Jan 5Jonathan SchechterDirectorDirector▲ BUY20,0000.7776$16K39+15%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 31, 2026. How we read filings

Report an error

Tell us what looks wrong on this page. We check every report against the original filing and fix mistakes on our corrections page.

Share this trade
XTelegram
My Desk · free

Sign in to follow

Follow stocks, members of Congress, famous investors and funds, and see what's new each time you come back.